APRI. Apricus Biosciences Announces Publication in Journal of Pharmaceutics and Drug Delivery Research Positive Data Demonstrates NexACT(R) Significantly Enhances Permeation of Tolnaftate-D(TM), the Company's OTC Product for Athlete's Foot http://finance.yahoo.com/news/apricus-biosciences-announces-publication-journal-192053054.html stockcharts.com/c-sc/sc?s=APRI&p=D&yr=0&mn=3&dy=0&i=t30685208756&r=1347914282918